Overview
Gauti Gislason practices in Reykjavik, Iceland. Gislason is rated as an Elite expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Their top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, Multiple Myeloma, and Small Lymphocytic Lymphoma (SLL).
Their clinical research consists of co-authoring 24 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 10 articles in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Distinguished
- Smoldering Multiple MyelomaGislason isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Multiple MyelomaGislason isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Chronic B-Cell Leukemia (CBCL)Gislason isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Gislason isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Small Lymphocytic Lymphoma (SLL)Gislason isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).